In the late autumn of 2019, a new potentially lethal human coronavirus designated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China. The pandemic spread of this zoonotic virus has created a global health emergency and an unprecedented socioeconomic crisis. The severity of coronavirus disease 2019 (COVID-19), the illness caused by SARS-CoV‑2, is highly variable. Most patients (~85%) develop no or mild symptoms, while others become seriously ill, some succumbing to disease-related complications. In this review, the SARS-CoV‑2 life cycle, its transmission and the clinical and immunological features of COVID-19 are described. In addition, an overview is presented of the virological assays for detecting ongoing SARS-CoV‑2 infections and the serological tests for SARS-CoV-2-specific antibody detection. Also discussed are the different approaches to developing a COVID-19 vaccine and the perspectives of treating COVID-19 with antiviral drugs, immunomodulatory agents and anticoagulants/antithrombotics. Finally, the cardiovascular manifestations of COVID-19 are briefly touched upon. While there is still much to learn about SARS-CoV‑2, the tremendous recent advances in biomedical technology and knowledge and the huge amount of research into COVID-19 raise the hope that a remedy for this disease will soon be found. COVID-19 will nonetheless have a lasting impact on human society. Electronic supplementary material The online version of this article (10.1007/s12471-020-01475-1) contains supplementary material, which is available to authorized users.
【저자키워드】 severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019, Vaccine, pandemic, acute respiratory distress syndrome, antiviral drug, 【초록키워드】 COVID-19, coronavirus disease, serological test, SARS-CoV-2, coronavirus, knowledge, severity, antiviral drugs, Transmission, virus, Spread, Antibody detection, zoonotic, Research, complications, disease, mild symptoms, SARS-CoV‑2, manifestation, Immunomodulatory agent, health emergency, acute respiratory syndrome, supplementary material, Perspective, treating COVID-19, while, SARS-CoV‑2 infection, immunological, feature, Wuhan, China, raise, described, develop, caused, approach, addition, Most patient, virological assay,